Open AccessMyeloma Patients Relapsing after First Line Treatment with Tandem Auto/Allo Transplant or Auto Transplant Only Have Similar Outcomes.
Author(s) -
JeanSébastien Claveau,
Richard LeBlanc,
Imran Ahmad,
Séverine Landais,
Nadia M. Bambace,
Léa Bernard,
Sandra Cohen,
JeanSébastien Delisle,
Thomas Kiss,
Silvy Lachance,
DenisClaude Roy,
Guy Sauvageau,
Jean Roy
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.469
Subject(s) - medicine , fludarabine , melphalan , multiple myeloma , hematopoietic stem cell transplantation , cyclophosphamide , cohort , transplantation , lenalidomide , surgery , gastroenterology , oncology , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom